LiSyM: The better way to manage your data
Free and open platform for easier research data management
Latest additions
Hepatic Hedgehog Signaling Participates in the Crosstalk between Liver and Adipose Tissue in Mice by Regulating FGF21
Publication - added 5 days agoThe rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis
Publication - added 5 days agoGenetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study
Publication - added 5 days agoTumour cells can escape antiproliferative pressure by interferon-β through immunoediting of interferon receptor expression
Publication - added 13 days agoRNAseq_raw_data_Hh_modulation_murine_hepatocytes
Data file - added 18 days agoHepatic Hedgehog Signaling Participates in the Crosstalk between Liver and Adipose Tissue in Mice by Regulating FGF21.
Publication - added 18 days agoBIOMD0000000064_url.xml Teusink SBML
Model - added 29 days agoSOP : Isolation of primary mouse hepatocytes
SOP - added about 1 month agoSOP : Western diat mouse housing and feeding
SOP - added about 1 month agoProteomic alterations in Western Diet (WD) hepatocytes
Study - added about 1 month ago
Find content
LiSyM (Liver Systems Medicine) represents a research network of German centers and institutions, brought together by a 20 Million Euro funding program of the German Government, in which mathematicians, modelers, pharmacologists, molecular biologists and clinical scientists work together to develop a Systems Medicine approach to study early and advanced liver disease.
The aim of this unique research program is to acquire and use new experimental data and data from existing data bases to build computational models that facilitate decision making at the patient's bedsite and to predict the actions of new medicines in the treatment of metabolic liver disease.